Comprehensive cross‐sectional study of CIN prevalence, HPV genotyping, genetic alterations, and microbiota as molecular biomarkers for early cervical cancer detection: A pilot clinical study among women in Russia

Documenti analoghi

• Letter to “Correlation of immediate prevalence of cervical squamous cell precancers and cancers with HPV genotype and age in women with LSIL cytology”
  di: Liqing Chen, et al.
  Pubblicazione: (2024)
• Human papillomavirus vaccine to prevent CIN3 or worse (CIN3+): A nationwide case–control study in Japan
  di: Sayaka Ikeda, et al.
  Pubblicazione: (2024)
• Circulating tumor HPV DNA as a specific biomarker for cervical cancer
  di: Tao Chen, et al.
  Pubblicazione: (2024)
• Cost‐effectiveness analysis of human papillomavirus ( HPV ) genotyping strategies for management of HPV ‐positive women in cervical cancer screening
  di: Kelsi R. Kroon, et al.
  Pubblicazione: (2026)
• Serum oxidative biomarkers associated with genital HPV infection and cervical lesions in women
  di: Hui‐Yi Lin, et al.
  Pubblicazione: (2024)